XPhyto Therapeutics Corporation products

XPhyto Therapeutics is focused on helping economies restart and businesses get up and running to bring life back to normal with a rapid, accurate and cost effective COVID test.

Clinical studies are planned in 2021 to demonstrate the efficient sublingual delivery of THC for anorexia and nausea.

Clinical studies are planned in 2021 to demonstrate the efficient transdermal delivery of a well-established Parkinson`s disease medication.

Clinical studies are planned in 2021 to demonstrate the efficient sublingual delivery of a combination of CBD and THC for Multiple Sclerosis-associated spasticity.

Clinical studies are planned in 2021 to demonstrate the efficient sublingual delivery of CBD for treatment-resistant Epilepsy.